Massimo Iacoviello

7.3k total citations · 1 hit paper
209 papers, 4.3k citations indexed

About

Massimo Iacoviello is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Massimo Iacoviello has authored 209 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Cardiology and Cardiovascular Medicine, 52 papers in Endocrinology, Diabetes and Metabolism and 47 papers in Surgery. Recurrent topics in Massimo Iacoviello's work include Heart Failure Treatment and Management (63 papers), Cardiovascular Function and Risk Factors (39 papers) and Diabetes Treatment and Management (31 papers). Massimo Iacoviello is often cited by papers focused on Heart Failure Treatment and Management (63 papers), Cardiovascular Function and Risk Factors (39 papers) and Diabetes Treatment and Management (31 papers). Massimo Iacoviello collaborates with scholars based in Italy, United States and Lebanon. Massimo Iacoviello's co-authors include Pietro Guida, Roberta Romito, Cinzia Forleo, P Rizzon, Maria Vittoria Pitzalis, Francesco Massari, Filippo Mastropasqua, Marco Matteo Ciccone, Sandro Sorrentino and Giovanni Luzzi and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Massimo Iacoviello

196 papers receiving 4.2k citations

Hit Papers

Cardiac resynchronization therapy tailored by echocardiog... 2002 2026 2010 2018 2002 100 200 300 400 500

Peers

Massimo Iacoviello
Massimo Iacoviello
Citations per year, relative to Massimo Iacoviello Massimo Iacoviello (= 1×) peers Tatsuya Maruhashi

Countries citing papers authored by Massimo Iacoviello

Since Specialization
Citations

This map shows the geographic impact of Massimo Iacoviello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Iacoviello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Iacoviello more than expected).

Fields of papers citing papers by Massimo Iacoviello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Iacoviello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Iacoviello. The network helps show where Massimo Iacoviello may publish in the future.

Co-authorship network of co-authors of Massimo Iacoviello

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Iacoviello. A scholar is included among the top collaborators of Massimo Iacoviello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Iacoviello. Massimo Iacoviello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scicchitano, Pietro, Massimo Iacoviello, Stefano Albani, et al.. (2025). Congestion and systemic inflammation in acute heart failure: correlations and prognostic role. Frontiers in Cardiovascular Medicine. 12. 1695500–1695500.
2.
Tricarico, Lucia, Vincenzo Ceci, Pietro Mazzeo, et al.. (2024). Left ventricular reverse remodeling after combined ARNI and SGLT2 therapy in heart failure patients with reduced or mildly reduced ejection fraction. IJC Heart & Vasculature. 54. 101492–101492. 4 indexed citations
3.
Abrignani, Maurizio Giuseppe, Edoardo Gronda, Marco Marini, et al.. (2024). Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem. Cardiovascular Drugs and Therapy. 39(4). 857–874. 2 indexed citations
5.
Palazzuoli, Alberto, Michele Correale, Massimo Iacoviello, & Edoardo Gronda. (2023). Does the Measurement of Ejection Fraction Still Make Sense in the HFpEF Framework? What Recent Trials Suggest. Journal of Clinical Medicine. 12(2). 693–693. 7 indexed citations
6.
Gronda, Edoardo, Massimo Iacoviello, Chiara Valenti, et al.. (2022). I meccanismi d’azione degli inibitori del cotrasportatore sodio-glucosio di tipo 2 ed i loro effetti benefici sull’assetto funzionale di cuore e rene. Giornale italiano di cardiologia. 23(11). 854–871. 1 indexed citations
7.
Lenarda, Andrea Di, Giuseppe Di Tano, Manlio Cipriani, et al.. (2021). Position paper ANMCO: Duplice, triplice o quadruplice terapia nello scompenso sistolico? Evidenze e nuove strategie. Giornale italiano di cardiologia. 22(10). 861–868. 1 indexed citations
8.
Rosano, Giuseppe, Massimo Iacoviello, & Pasquale Perrone Filardi. (2021). La “serendipity” degli inibitori del co-trasportatore sodio-glucosio di tipo 2: un nuovo paradigma nello scompenso cardiaco con frazione di eiezione ridotta. Giornale italiano di cardiologia. 22(4). 277–283. 2 indexed citations
10.
Gronda, Edoardo, Massimo Iacoviello, Pasquale Caldarola, et al.. (2021). Inibitori del co-trasportatore sodio-glucosio di tipo 2: meccanismi d’azione renale. Le implicazioni nel diabete e nello scompenso cardiaco. Giornale italiano di cardiologia. 22(4). 284–291. 2 indexed citations
11.
Tano, Giuseppe Di, Andrea Di Lenarda, Massimo Iacoviello, et al.. (2021). Position paper ANMCO: Utilizzo di sacubitril/valsartan nel paziente ricoverato con scompenso cardiaco acuto. Giornale italiano di cardiologia. 22(10). 854–860. 1 indexed citations
12.
Gronda, Edoardo, Pasquale Caldarola, Massimo Iacoviello, & Domenico Gabrielli. (2020). Linee guida europee su diabete, pre-diabete e malattie cardiovascolari: cosa c’è di nuovo? Il punto di vista del cardiologo. Giornale italiano di cardiologia. 21(4). 246–251. 1 indexed citations
13.
Tano, Giuseppe Di, Andrea Di Lenarda, Domenico Gabrielli, et al.. (2018). Position paper ANMCO sull’utilizzo della terapia con sacubitril/valsartan nel paziente con scompenso cardiaco. Giornale italiano di cardiologia. 19(10). 568–590. 3 indexed citations
14.
Marini, Marco, Giorgio Caretta, Fabiana Lucà, et al.. (2017). Ventilazione non invasiva e sedazione: evidenze a supporto e consigli pratici. Giornale italiano di cardiologia. 18(6). 513–518. 1 indexed citations
15.
Marini, Marco, Fabiana Lucà, Giorgio Caretta, et al.. (2017). Shock cardiogeno: dal trattamento farmacologico all’assistenza meccanica al circolo. Giornale italiano di cardiologia. 18(10). 708–718. 2 indexed citations
16.
Aspromonte, Nadia, Michele Massimo Gulizia, Aldo Clerico, et al.. (2016). Documento di consenso ANMCO/ELAS/SIBioC: Raccomandazioni sull’impiego dei biomarcatori cardiaci nello scompenso cardiaco. Giornale italiano di cardiologia. 17(9). 615–656. 3 indexed citations
17.
Aspromonte, Nadia, Michele Massimo Gulizia, Andrea Di Lenarda, et al.. (2016). Documento di consenso ANMCO/SIC. La rete cardiologica per la cura del malato con scompenso cardiaco: organizzazione dell’assistenza ambulatoriale. Giornale italiano di cardiologia. 17(7). 570–93. 3 indexed citations
18.
Ciccone, Marco Matteo, Annapaola Zito, Ilaria Dentamaro, et al.. (2015). Deficit di vitamina D e malattie cardiovascolari. Giornale italiano di cardiologia. 16(1). 16–20. 9 indexed citations
19.
Ciccone, Marco Matteo, Massimo Iacoviello, Loreto Gesualdo, et al.. (2013). The Renal Arterial Resistance Index: A Marker of Renal Function with an Independent and Incremental Role in Predicting Heart Failure Progression. European Journal of Heart Failure. 16(2). 210–216. 54 indexed citations
20.
Pitzalis, Maria Vittoria, John M. Hamlyn, Elisabetta Messaggio, et al.. (2005). Independent and Incremental Prognostic Value of Endogenous Ouabain in Idiopathic Dilated Cardiomyopathy. European Journal of Heart Failure. 8(2). 179–186. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026